Cargando…

Early chronic suppression of microglial p38α in a model of Alzheimer’s disease does not significantly alter amyloid-associated neuropathology

The p38 alpha mitogen-activated protein kinase (p38α) is linked to both innate and adaptive immune responses and is under investigation as a target for drug development in the context of Alzheimer’s disease (AD) and other conditions with neuroinflammatory dysfunction. While preclinical data has show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braun, David J., Frazier, Hilaree N., Davis, Verda A., Coleman, Meggie J., Rogers, Colin B., Van Eldik, Linda J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231773/ https://www.ncbi.nlm.nih.gov/pubmed/37256881 http://dx.doi.org/10.1371/journal.pone.0286495

Ejemplares similares

Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease
por: Braun, David J., et al.
Publicado: (2020)

Possible Neuropathology of Sleep Disturbance Linking to Alzheimer’s Disease: Astrocytic and Microglial Roles
por: Xiao, Shu-Yun, et al.
Publicado: (2022)

Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
por: Tanaka, Mikiei, et al.
Publicado: (2020)

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
por: Amadoru, Sanka, et al.
Publicado: (2020)

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
por: Wang, Jun, et al.
Publicado: (2011)

Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
por: Bachstetter, Adam D, et al.
Publicado: (2011)

Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα
por: Xing, Bin, et al.
Publicado: (2011)

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission
por: Jaunmuktane, Zane, et al.
Publicado: (2021)

CSF β-amyloid and white matter damage: unravelling the neuropathology of Alzheimer’s disease
por: Sousa Alves, Gilberto
Publicado: (2018)

Transcriptional Signatures of Tau and Amyloid Neuropathology
por: Castanho, Isabel, et al.
Publicado: (2020)

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
por: El Hajj, Hassan, et al.
Publicado: (2019)

Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
por: Martini, Alessandra C., et al.
Publicado: (2020)

The microvascular extracellular matrix in brains with Alzheimer’s disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA)
por: Damodarasamy, Mamatha, et al.
Publicado: (2020)

Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
por: Patrick, Ellis, et al.
Publicado: (2017)

Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
por: Nicoll, James A R, et al.
Publicado: (2019)

Analyzing microglial phenotypes across neuropathologies: a practical guide
por: Schwabenland, Marius, et al.
Publicado: (2021)

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
por: Liu, Ruiyuan, et al.
Publicado: (2019)

Microglial responses to amyloid β peptide opsonization and indomethacin treatment
por: Strohmeyer, Ronald, et al.
Publicado: (2005)

Spatial proteomics reveals human microglial states shaped by anatomy and neuropathology
por: Mrdjen, Dunja, et al.
Publicado: (2023)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles
por: Glat, Micaela, et al.
Publicado: (2013)

The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology
por: Canu, Nadia, et al.
Publicado: (2017)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Neuropathological correlates and genetic architecture of microglial activation in elderly human brain
por: Felsky, Daniel, et al.
Publicado: (2019)

COVID‐19‐related neuropathology and microglial activation in elderly with and without dementia
por: Poloni, Tino Emanuele, et al.
Publicado: (2021)

Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
por: Yu, Fengxiang, et al.
Publicado: (2015)

Amyloid β Induces Lipid Droplet-Mediated Microglial Dysfunction in Alzheimer’s Disease
por: Prakash, Priya, et al.
Publicado: (2023)

Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid
por: Craft, Jeffrey M, et al.
Publicado: (2005)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

MFG-E8 Regulates Microglial Phagocytosis of Apoptotic Neurons
por: Fuller, Abby D., et al.
Publicado: (2008)

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
por: Reas, Emilie T., et al.
Publicado: (2017)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
por: Doher, Nicholas, et al.
Publicado: (2023)

Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology
por: Martersteck, Adam, et al.
Publicado: (2022)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

Deep learning from multiple experts improves identification of amyloid neuropathologies
por: Wong, Daniel R., et al.
Publicado: (2022)

Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
por: Silva, Jaime, et al.
Publicado: (2022)

In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
por: Braun, David J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ed8uej7ahf744vppi5q5us3gn6